Transcend Therapeutics
Luke Frering is a Clinical Trial Manager with experience at Transcend Therapeutics and Relmada Therapeutics, Inc. Previously, Luke worked as a Clinical Research Associate II, Clinical Research Associate, and Clinical Trials Assistant at Axsome Therapeutics, Inc. Additionally, Luke interned at Crouse Health and held positions as a Fitness Center Attendant and Research Assistant during time at Syracuse University. Luke holds a Bachelor of Science in Health and Exercise Science from Syracuse University, awarded in 2018.
Transcend Therapeutics
1 followers
Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing next-generation psychoactive medicines for neuropsychiatric disease. Transcend develops medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have real-world data showing that our lead product provided significant benefit to >85% of patients with PTSD and depression. We have already advanced our lead compound into an approved Phase II study in PTSD, with plans to expand into depression and other indications.